Gan Zhongru is a Chinese businessman and self-made billionaire, the Cofounder and Chairman of Shanghai-listed Gan & Lee Pharmaceuticals (SHA: 603087). The company, founded in 1998, is a major producer of insulin and injection pens.

Gan graduated from Peking University and later became a teacher in the biology department. He also holds a PhD from Michigan State University and worked for Merck before starting Gan & Lee.

• Core Company: Gan & Lee Pharmaceuticals (SHA: 603087), specializing in insulin production.
• Education: Graduate of Peking University and Michigan State University (PhD).
• Prior Experience: Worked for the pharmaceutical giant Merck.

Gan Zhongru’s career is defined by his scientific expertise and pharmaceutical innovation. After extensive academic training and a stint at Merck, he founded Gan & Lee Pharmaceuticals in 1998, focusing on the critical market of insulin production.

The company, which produces both insulin and injection pens, successfully went public in Shanghai in 2020. His wealth is secured by the company's leading position in the essential diabetes care market in China.